Skip to main content

Table 3 Multivariate Cox regression (Survival)

From: Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model

   HR 95% CI p
Model 1 MSKCC - Risk Group    
     Favourable 1 - -
     Intermediate 8.06 1.09-59.59 0.041
     Poor 18.21 2.42-136.88 0.005
Model 2 Metastatic sites    
     1 1 - -
     >1 3.67 1.56-8.66 0.003
  Time between diagnosis/surgery and Sunitinib initiation    
     <= 12 months 1 - -
     >12 months 0.36 0.19-0.67 0.001
  Performance Status    
     <= 1 1 - -
     >1 3.04 1.46-6.32 0.003
Model 3 4-Groups    
     0 risk 1 - -
     1 risk 5.64 0.75-42.39 0.093
     2 risk 14.62 1.97-108.26 0.009
     3 risk 51.20 6.09-430.42 0.000
Model 4 3-Groups    
     0 or 1 risk 1 - -
     2 risk 3.26 1.76-6.06 0.000
     3 risk 11.45 4.41-29.74 0.000
Model 5 2-Groups    
     0 or 1 risk 1 - -
     2 or 3 risk 3.63 2.01-6.57 0.000